Colon Cancer: Receptors, Signalling and Therapeutics [ 2004 - 2008 ]

Research Grant

Researchers: Prof Antony Burgess (Principal investigator) ,  Dr Thomas Garrett ,  Prof Andrew Scott ,  Prof Richard Simpson

Brief description This program aims to understand the biochemical and biological basis of colorectal cancer, a major cause of cancer deaths in Australia. The Chief Investigators have extensive experience in the analysis of the molecular defects in colorectal cancer cells and have already developed new drugs to treat successfully experimental colon tumours in animals. During this research program, we will explore these systems further, concentrating on the identification of novel inhibitors of colon cancer cell growth, survival and movement. Newly developed instruments and techniques will allow us to identify and detect the critical steps during the development of colorectal cancer and to design potent drugs to fight the disease. We have experience in conducting novel clinical trials in colon cancer and have developed imaging techniques for monitoring the effectiveness and safety of new anti-cancer drugs. Our collective scientific experience and ability to work in the clinic provides a unique opportunity for developing more effective treatments for colorectal cancer patients.

Funding Amount $AUD 7,115,542.50

Funding Scheme Programs

Notes Program Grant